AlloVir Statistics

Total Valuation

AlloVir has a market cap or net worth of $106.13 million. The enterprise value is -$19.50 million.

Market Cap	106.13M
Enterprise Value	-19.50M

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

AlloVir has 114.12 million shares outstanding. The number of shares has increased by 25.13% in one year.

Shares Outstanding	114.12M
Shares Change (YoY)	+25.13%
Shares Change (QoQ)	+0.38%
Owned by Insiders (%)	20.13%
Owned by Institutions (%)	19.75%
Float	28.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.84
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 55.08, with a Debt / Equity ratio of 0.07.

Current Ratio	55.08
Quick Ratio	54.98
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -80.33% and return on invested capital (ROIC) is -38.76%.

Return on Equity (ROE)	-80.33%
Return on Assets (ROA)	-36.53%
Return on Capital (ROIC)	-38.76%
Revenue Per Employee	n/a
Profits Per Employee	-$1.25M
Employee Count	112
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-126,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.73% in the last 52 weeks. The beta is 0.78, so AlloVir's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	-36.73%
50-Day Moving Average	0.79
200-Day Moving Average	0.76
Relative Strength Index (RSI)	71.15
Average Volume (20 Days)	218,430

Short Selling Information

The latest short interest is 4.89 million, so 4.29% of the outstanding shares have been sold short.

Short Interest	4.89M
Short Previous Month	5.50M
Short % of Shares Out	4.29%
Short % of Float	17.11%
Short Ratio (days to cover)	26.44

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-120.89M
Pretax Income	-179.66M
Net Income	-140.34M
EBITDA	-120.47M
EBIT	-120.89M
Earnings Per Share (EPS)	-$1.23

Full Income Statement

Balance Sheet

The company has $129.61 million in cash and $9.00 million in debt, giving a net cash position of $120.61 million or $1.06 per share.

Cash & Cash Equivalents	129.61M
Total Debt	9.00M
Net Cash	120.61M
Net Cash Per Share	$1.06
Equity (Book Value)	120.29M
Book Value Per Share	1.05
Working Capital	127.58M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-120.91M
Capital Expenditures	n/a
Free Cash Flow	-120.91M
FCF Per Share	-$1.06

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AlloVir does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.13%
Shareholder Yield	-25.13%
Earnings Yield	-138.80%
FCF Yield	-119.58%

Analyst Forecast

The average price target for AlloVir is $1.00, which is 7.53% higher than the current price. The consensus rating is "Sell".

Price Target	$1.00
Price Target Difference	7.53%
Analyst Consensus	Sell
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2